Literature DB >> 16438966

Neurogenin2 identifies a transplantable dopamine neuron precursor in the developing ventral mesencephalon.

Lachlan H Thompson1, Elin Andersson, Josephine B Jensen, Perrine Barraud, Francois Guillemot, Malin Parmar, Anders Björklund.   

Abstract

In neural transplantation studies, there is an interest in identifying and isolating mesencephalic dopamine (mesDA) neuron precursors that have the capacity to differentiate into fully mature mesDA neurons after transplantation. We report here that in the developing ventral mesencephalon (VM) the proneural gene Neurogenin2 (Ngn2) is expressed exclusively in the part of the ventricular zone that gives rise to the migrating mesDA neuroblasts, but not in the differentiated mesDA neurons. From other studies, we know that Ngn2 is involved in the generation of mesDA neurons and that the development of mesDA neurons is severely compromised in Ngn2-null mutant mice. We show here that cells isolated by FACS from the developing VM of Ngn2-GFP knock-in mice are capable of generating mesDA neurons, both in vitro and after transplantation to the striatum of neonatal rats. All mesDA neuron precursors, but not the serotonergic or GABAergic neuron precursors, are contained in the Ngn2-GFP-expressing population. Moreover, all glial cells were generated from cells contained in the GFP-negative cell fraction. The results show that surviving mesDA neurons in VM grafts are derived from early postmitotic, probably Nurr1-expressing precursors before they have acquired their fully differentiated neuronal phenotype. The Ngn2-GFP reporter construct used here thus provides a tool for the identification of mesDA neuron precursors in the VM and selective isolation of transplantable mesDA neuron precursors for transplantation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16438966     DOI: 10.1016/j.expneurol.2005.11.025

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  17 in total

1.  Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells.

Authors:  Stina Friling; Elisabet Andersson; Lachlan H Thompson; Marie E Jönsson; Josephine B Hebsgaard; Evanthia Nanou; Zhanna Alekseenko; Ulrika Marklund; Susanna Kjellander; Nikolaos Volakakis; Outi Hovatta; Abdeljabbar El Manira; Anders Björklund; Thomas Perlmann; Johan Ericson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-21       Impact factor: 11.205

2.  Sorting the wheat from the chaff in dopamine neuron-based cell therapies.

Authors:  Ole Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

3.  Isolation of LMX1a Ventral Midbrain Progenitors Improves the Safety and Predictability of Human Pluripotent Stem Cell-Derived Neural Transplants in Parkinsonian Disease.

Authors:  Isabelle R de Luzy; Jonathan C Niclis; Carlos W Gantner; Jessica A Kauhausen; Cameron P J Hunt; Charlotte Ermine; Colin W Pouton; Lachlan H Thompson; Clare L Parish
Journal:  J Neurosci       Date:  2019-10-22       Impact factor: 6.167

4.  Thyroid Hormone-Otx2 Signaling Is Required for Embryonic Ventral Midbrain Neural Stem Cells Differentiated into Dopamine Neurons.

Authors:  Chunhai Chen; Qinglong Ma; Xiaowei Chen; Min Zhong; Ping Deng; Gang Zhu; Yanwen Zhang; Lei Zhang; Zhiqi Yang; Kuan Zhang; Lu Guo; Liting Wang; Zhengping Yu; Zhou Zhou
Journal:  Stem Cells Dev       Date:  2015-06-17       Impact factor: 3.272

5.  Transcriptome analysis reveals transmembrane targets on transplantable midbrain dopamine progenitors.

Authors:  Chris R Bye; Marie E Jönsson; Anders Björklund; Clare L Parish; Lachlan H Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-09       Impact factor: 11.205

6.  A PBX1 transcriptional network controls dopaminergic neuron development and is impaired in Parkinson's disease.

Authors:  J Carlos Villaescusa; Bingsi Li; Enrique M Toledo; Pia Rivetti di Val Cervo; Shanzheng Yang; Simon Rw Stott; Karol Kaiser; Saiful Islam; Daniel Gyllborg; Rocio Laguna-Goya; Michael Landreh; Peter Lönnerberg; Anna Falk; Tomas Bergman; Roger A Barker; Sten Linnarsson; Licia Selleri; Ernest Arenas
Journal:  EMBO J       Date:  2016-06-28       Impact factor: 11.598

7.  Cellular programming and reprogramming: sculpting cell fate for the production of dopamine neurons for cell therapy.

Authors:  Julio C Aguila; Eva Hedlund; Rosario Sanchez-Pernaute
Journal:  Stem Cells Int       Date:  2012-09-04       Impact factor: 5.443

8.  Restriction of neural precursor ability to respond to Nurr1 by early regional specification.

Authors:  Chiara Soldati; Emanuele Cacci; Stefano Biagioni; Nicoletta Carucci; Giuseppe Lupo; Carla Perrone-Capano; Isabella Saggio; Gabriella Augusti-Tocco
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

Review 9.  Midbrain dopaminergic neuron fate specification: Of mice and embryonic stem cells.

Authors:  Emily Gale; Meng Li
Journal:  Mol Brain       Date:  2008-09-30       Impact factor: 4.041

Review 10.  Cell based therapies in Parkinson's Disease.

Authors:  Madhuri Behari; Kapil Kumar Singhal
Journal:  Ann Neurosci       Date:  2011-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.